These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 25874161
1. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease. Kass-Iliyya L, Kobylecki C, McDonald KR, Gerhard A, Silverdale MA. Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161 [Abstract] [Full Text] [Related]
2. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Numao A, Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021 [Abstract] [Full Text] [Related]
3. The interrelationship between non-motor symptoms in Atypical Parkinsonism. Lee CN, Kim M, Lee HM, Jang JW, Lee SM, Kwon DY, Park KW, Koh SB. J Neurol Sci; 2013 Apr 15; 327(1-2):15-21. PubMed ID: 23428208 [Abstract] [Full Text] [Related]
4. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ashour R, Jankovic J. Mov Disord; 2006 Nov 15; 21(11):1856-63. PubMed ID: 16941460 [Abstract] [Full Text] [Related]
5. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy]. Yoshita M, Hayashi M, Hirai S. Rinsho Shinkeigaku; 1997 Jun 15; 37(6):476-82. PubMed ID: 9366173 [Abstract] [Full Text] [Related]
6. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy. Malkiewicz JJ, Siuda J. Neurol Neurochir Pol; 2024 Jun 15; 58(2):193-202. PubMed ID: 38148738 [Abstract] [Full Text] [Related]
7. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M. J Neurol; 2018 Nov 15; 265(11):2602-2613. PubMed ID: 30178175 [Abstract] [Full Text] [Related]
8. Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study. Avenali M, Tassorelli C, De Icco R, Perrotta A, Serrao M, Fresia M, Pacchetti C, Sandrini G. Clin Neurophysiol; 2017 Oct 15; 128(10):1978-1984. PubMed ID: 28829981 [Abstract] [Full Text] [Related]
11. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease. Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R. J Neural Transm (Vienna); 2019 Nov 15; 126(11):1437-1445. PubMed ID: 31432258 [Abstract] [Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Paviour DC, Thornton JS, Lees AJ, Jäger HR. Mov Disord; 2007 Jan 15; 22(1):68-74. PubMed ID: 17089396 [Abstract] [Full Text] [Related]
13. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F. J Neural Transm (Vienna); 2003 Feb 15; 110(2):151-69. PubMed ID: 12589575 [Abstract] [Full Text] [Related]